ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

Cardiovascular disease

Congestive heart failure first year

Dose dependent

Less than 1% up to 300 mg/m²

doxorubicine/adriamycine

26% over 500mg/m²

Swain 2003